Saredutant

Saredutant
	File:Saredutant.png
Identifiers
	IUPAC name N-[(2S)-4-(4-acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide;
CAS Number	142001-63-6;
PubChem CID	104974;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C31H35Cl2N3O2
Molar mass	552.5345 g/mol

Saredutant, or SR 48968, is a neurokinin-2 antagonist drug being developed as an antidepressant and anxiolytic by sanofi-aventis. Its mechanism of action is different from antidepressants currently available on the market. It works by blocking the effects of Neurokinin A at the NK-2 receptor.

Phase III studies are currently being conducted.

Template:Pharma-stub

Template:WikiDoc Sources

Identifiers
File:Saredutant.png
IUPAC name N-[(2S)-4-(4-acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide
CAS Number	142001-63-6
PubChem CID	104974
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₃₁H₃₅Cl₂N₃O₂
Molar mass	552.5345 g/mol

Saredutant

Navigation menu